N,N'-Di(2-naphthyl)-N,N'-diphenyl-1,4-phenylenediamine>98.0%(HPLC)(N)1g

1-([(TERT-BUTOXY)CARBONYL]AMINO)-2-METHYLCYCLOBUTANE-1-CARBOXYLIC ACID, 95%, 250mg

(2,5-Difluorophenyl)(piperazin-1-yl)methanone hydrochloride, 98%, 5g

4-BROMO-2-METHYL-6-NITROBENZONITRILE, 95.0%, 5g

Methyl 1-methyl-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 98+%, 1g

(2-(Ethylsulfonyl)phenyl)boronic acid, 95.0%, 250mg

2-(2H-Benzo[d][1,2,3]triazol-2-yl)-4-methylphenol, 95.0%, 500g

2',6'-dichloroacetanilide, 98+%, 1g

1-((R)-3-Hydroxy-pyrrolidin-1-yl)-ethanone, 95.0%, 5g

Nanopolvo de óxido de cobre(II) 99+% APS 30-50 nm 50 g

Heptamolibdato de amonio tetrahidratado, mínimo 99 %, extrapuro, 100 g, envase de plástico.

3-(1-Oxo-5-(piperazin-1-yl)isoindolin-2-yl)piperidine-2,6-dione hydrochloride, 98%, 1g

4-Chloro-6-fluoro-8-methoxyquinoline-3-carbonitrile, 95%, 250mg